A sequel for beginners, part 2: ligand-based drug design — the basics

webinar

Tue, 18 Feb 2014, 17:00 CET (Berlin)

A sequel for beginners, part 2: ligand-based drug design — the basics

“But we don’t have a protein structure!&quot – it’s a common complaint in drug hunting. In fact, you don’t have your back to the wall if you need to spot active compounds in this situation! In this BioSolveIT webinar, you will learn the background to basic techniques such as ligand superposition. By the end of the hour, you will have learned how the impossible becomes possible, intelligently mining for interesting and synthetically feasible leads from gigantically large spaces of potential compounds in just a few minutes.

Current news

What's So Special About The 'Activity Spotter'? Detailed Insights Into SeeSAR's New Mode
April 29, 2026 10:22 CEST
SeeSAR’s Activity Spotter Mode is designed to dismantle the barrier of raw data and actionable SAR. It helps to answer the most relevant fields in hit-to-lead and lead optimization campaigns: 3D SAR and pharmacophore modeling. Which structural features in my molecule set are associated with activity? Which ones are linked...
Read on
Tool of the Month - FlexX
April 29, 2026 08:53 CEST
Spring is Molecular Docking Season The bread and butter of computational chemistry: predicting potential binding modes, which serves as a crucial foundation for SAR analysis and design decisions, is being made available to everyone this month with the proprietary docking tool FlexX. Validated by over 10,000 citations of its original...
Read on
The 95 Billion Update: Access the REAL Space
April 9, 2026 13:57 CEST
The latest update of Enamine’s REAL Space brings a new expansion, now featuring over 94.5 billion accessible, drug-like products, approaching the 100 billion mark. Built from 173 curated reaction protocols and 202,620 in-stock reagents and building blocks based on Enamine’s in-house knowledge, this version further enhances the world’s largest commercially...
Read on